艾迪药业(688488.SH)：目前出口业务量在公司整体营收中占比较小

Group 1 - The core viewpoint of the article is that overseas expansion is a significant development strategy for the company [1] - The company's export business currently accounts for a small proportion of its overall revenue [1] - The company will continue to deepen its diversified exploration of overseas markets to cultivate new growth points and enhance international competitiveness [1]